By Michalis Theodoropoulos
Over the previous decade, Greece has typically introduced itself as a rustic embracing a contemporary hashish coverage. Industrial hemp cultivation was legalized in 2016, medical hashish laws adopted in 2018, and important investments had been attracted in cultivation, processing and pharmaceutical hashish manufacturing. On paper, Greece appeared able to grow to be a regional chief within the European hashish sector.
Nevertheless, the newest legislative developments reveal a unique actuality: a market that continues to be closely restricted, overregulated, characterised by authorized uncertainty and, in lots of respects, nonetheless influenced by prohibition-era pondering quite than evidence-based regulation.
The current amendments launched below Legislation 5302/2026 signify a major setback for the hemp and CBD sector. Whereas the acknowledged goal is to fight the proliferation of artificial psychoactive cannabinoids which have flooded elements of the retail market lately, the measures adopted go far past focusing on unlawful merchandise.
As a substitute of focusing enforcement efforts on artificial cannabinoids and merchandise intentionally marketed for intoxication, the laws imposes a blanket ban on the retail sale, possession and use of hemp flowers containing lower than 0.3% THC. These merchandise are non-intoxicating agricultural commodities legally cultivated all through the European Union and traded in quite a few Member States.
Off the market
Because of this, pure CBD hemp flowers have successfully been faraway from the Greek retail market, even if they had been by no means the first supply of the general public well being issues cited by policymakers.
This strategy raises essential questions relating to proportionality, authorized certainty and compatibility with the rules of the European Single Market. Quite than distinguishing between compliant pure hemp merchandise and illicit artificial substances, lawmakers have largely chosen the less complicated path of prohibition.
The identical restrictive philosophy extends to the broader CBD market, not solely in Greece however more and more throughout Europe, because the sector faces rising uncertainty relating to Novel Meals authorizations, toxicity assessments and evolving regulatory interpretations.
The brand new authorized framework in Greece strikes towards limiting the distribution of CBD merchandise to licensed hashish shops and pharmacies, whereas creating uncertainty for present gross sales channels corresponding to well being meals shops, natural retailers and wellness retailers which have operated legally for years.
Better uncertainty
Though hemp meals seem to stay outdoors the scope of the brand new restrictions, the general course of coverage is obvious: tighter management, fewer distribution channels and elevated regulatory uncertainty.
For entrepreneurs, buyers and worldwide companions, uncertainty is commonly extra damaging than regulation itself. Companies can adapt to clear guidelines. What they wrestle with is ambiguity, inconsistent interpretation, undefined enforcement mechanisms and a consistently shifting regulatory setting.
On the identical time, Greece continues to take care of probably the most restrictive medical hashish frameworks in Europe. The present regulatory setting dangers making a extremely concentrated market construction and favors a really restricted variety of operators able to navigating the pharmaceutical pathway. Whereas the federal government actively promotes funding in pharmaceutical hashish cultivation and manufacturing, affected person entry stays extremely restricted and restricted to particular therapeutic indications. Solely a small variety of merchandise are anticipated to achieve the market, prescribing stays tightly managed, and reimbursement mechanisms are absent.
Cut up character
This creates a paradox. On one hand, the state encourages funding in pharmaceutical hashish manufacturing, whereas more and more targeted on channeling all the cannabinoid demand solely by a tightly managed medical framework, and seeks to place Greece as a hub for cannabinoid-related funding. However, it restricts entry to hemp merchandise, narrows CBD distribution channels and maintains important boundaries to affected person entry.
The result’s a system the place manufacturing is inspired, however market improvement stays constrained. In observe, Greece seems prepared to help hashish manufacturing, however stays reluctant to normalize hashish entry.
Critics more and more argue that Greece is changing one type of prohibition with one other. As a substitute of making a balanced and fashionable regulatory framework that clearly distinguishes between industrial hemp, wellness CBD merchandise, medical cannabinoids, intoxicating substances and potential future adult-use markets, policymakers proceed to deal with hashish primarily as a threat to be managed quite than an financial, agricultural and healthcare alternative to be developed.
Impacting shoppers
The implications prolong past enterprise. Hundreds of shoppers who beforehand used authorized CBD merchandise for wellness functions face lowered entry. Sufferers thinking about cannabinoid-based therapies encounter restricted product availability and important entry boundaries. Home producers lose market alternatives and face rising aggressive disadvantages, whereas new market entrants encounter important boundaries to entry. Worldwide buyers face uncertainty relating to the long-term course of coverage. Most significantly, Greece dangers dropping its aggressive benefit at a time when the worldwide cannabinoid sector is evolving quickly.
Whereas nations corresponding to Germany, Switzerland, the Czech Republic and Luxembourg proceed to discover extra balanced and pragmatic regulatory fashions for hemp, medical and adult-use hashish, Greece dangers transferring in the other way. Extreme restrictions, authorized uncertainty and restricted market entry could discourage innovation, scale back funding and in the end weaken the nation’s place inside the rising European cannabinoid economic system.
A contemporary hashish coverage needs to be primarily based on three elementary rules: public well being safety, client security and financial improvement. These objectives should not mutually unique. Artificial cannabinoids needs to be aggressively faraway from the market. Minors needs to be protected. Product high quality needs to be strictly monitored. Clear labeling, laboratory testing and traceability necessities needs to be obligatory. Nevertheless, none of those aims require the blanket prohibition of pure hemp flowers or extreme restrictions on compliant CBD merchandise.
Discover a center floor
The way forward for hashish regulation in Greece shouldn’t be a alternative between prohibition and pharmaceutical management. A contemporary framework can concurrently defend public well being, encourage innovation, help home agriculture, create high-value jobs and guarantee protected entry for shoppers and sufferers.
The problem is just not whether or not hashish needs to be regulated. The problem is whether or not regulation can be designed to unlock the sector’s full financial and healthcare potential, or whether or not it’ll proceed to be formed primarily by concern, restriction and regulatory warning.
Greece has already demonstrated that it may possibly appeal to funding and construct a hashish business. The following step is to create a regulatory setting that enables this business to flourish. In any other case, the nation could discover itself investing sooner or later whereas regulating as if it had been nonetheless afraid of the previous.
Michalis Theodoropoulos is the founder and CEO of KANNABIO Social Cooperative.
